THE FOUNDATION FOR AIDS RESEARCH: Form 990, tax year 2015
View the entire original 990 at ProPublica ↗
- Organization
- THE FOUNDATION FOR AIDS RESEARCH (EIN 13-3163817)
- Tax period
- 2015-10-01 to 2016-09-30
- Filed
- 2017-06-20
- IRS object ID
- 201721719349300742
- Schema version
- 2015v3.0
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule G
- Schedule I
- Schedule J
- Schedule M
- Schedule O
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2017-06-20T15:04:19-05:00 | ReturnTs |
| Tax Period End | 2016-09-30 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | GRANT THORNTON LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 757 THIRD AVE 4TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 100172013 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2015-10-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 133163817 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | THE FOUNDATION FOR AIDS RESEARCH | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| In Care Of | % BRADLEY JENSEN | InCareOfNm |
| Business Name Control | FOUN | BusinessNameControlTxt |
| Phone | 2128061600 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 120 wall street 13TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 100053908 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | BRADLEY JENSEN | PersonNm |
| Person Title | ASSISTANT TREAS./CFO | PersonTitleTxt |
| Phone | 2128061703 | PhoneNum |
| Signature | 2017-06-20 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | Scott Thompsett | PreparerPersonNm |
| PTIN | P00741490 | PTIN |
| Phone | 2125990100 | PhoneNum |
| Preparation | 2017-06-20 | PreparationDt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2015 | TaxYr |
| Build TS | 2021-01-29 14:40:06Z | BuildTS |
Form 990 IRS990
Doing Business As Name DoingBusinessAsName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | Aids Research Foundation or amfAR | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | KEVIN FROST | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 120 WALL STREET 13TH FLOOR | AddressLine1Txt |
| City | new york | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10005 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $72,055,723 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.AMFAR.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1983 | FormationYr |
| Legal Domicile State | NY | LegalDomicileStateCd |
| Activity Or Mission | amfar is dedicated to ending the global AIDS EPIDEMIC THROUGH INNOVATIVE RESEARCH. | ActivityOrMissionDesc |
| Voting Members Governing Body | 17 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 17 | VotingMembersIndependentCnt |
| Total Employee | 85 | TotalEmployeeCnt |
| Total Volunteers | 0 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $56,251,128 | PYContributionsGrantsAmt |
| CY Contributions Grants | $58,810,206 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | $1,528,180 | PYInvestmentIncomeAmt |
| CY Investment Income | $1,108,834 | CYInvestmentIncomeAmt |
| PY Other Revenue | -$10,047,530 | PYOtherRevenueAmt |
| CY Other Revenue | -$11,056,842 | CYOtherRevenueAmt |
| PY Total Revenue | $47,731,778 | PYTotalRevenueAmt |
| CY Total Revenue | $48,862,198 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $9,528,182 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $10,349,259 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $10,307,568 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $10,487,770 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $739,793 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $854,723 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $5,918,761 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $17,000,831 | PYOtherExpensesAmt |
| CY Other Expenses | $19,985,556 | CYOtherExpensesAmt |
| PY Total Expenses | $37,576,374 | PYTotalExpensesAmt |
| CY Total Expenses | $41,677,308 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $10,155,404 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $7,184,890 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $71,251,093 | TotalAssetsBOYAmt |
| Total Assets EOY | $80,773,661 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $18,212,471 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $19,134,481 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $53,038,622 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $61,639,180 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | THE FOUNDATION FOR AIDS RESEARCH IS AN INTERNATIONAL NOT-FOR-PROFIT ORGANIZATION INCORPORATED IN NEW YORK IN 1989. AMFAR WAS FORMED THROUGH THE UNIFICATION IN 1985 OF TWO NOT-FOR-PROFIT ORGANIZATIONS, THE AIDS MEDICAL FOUNDATION ("AMF"), INCORPORATED IN NEW YORK IN APRIL 1983, AND THE NATIONAL AIDS RESEARCH FOUNDATION, INCORPORATED IN CALIFORNIA IN AUGUST 1985. FIRST BASED IN CALIFORNIA, AMFAR TRANSFERRED ITS LEGAL DOMICILE TO NEW YORK IN 1989, USING THE INITIAL INCORPORATION DOCUMENTS OF AMF, MAKING IT AMF'S LEGAL SUCCESSOR. AMFAR HAS OFFICES IN NEW YORK, NY, WASHINGTON, D.C., AND BANGKOK, THAILAND. ON MARCH 7, 2005, THE BOARD OF TRUSTEES OF THE AMERICAN FOUNDATION FOR AIDS RESEARCH APPROVED A CHANGE IN LEGAL NAME TO "THE FOUNDATION FOR AIDS RESEARCH." ON OCTOBER 18, 2005, THE NEW YORK STATE DEPARTMENT OF STATE APPROVED THIS CHANGE. IN ADDITION, THE FOUNDATION HAS SECURED APPROVAL FOR DOING BUSINESS AS (DBA) THE FOLLOWING: - AMERICAN FOUNDATION FOR AIDS RESEARCH - AMFAR - AIDS RESEARC | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $20,212,802 | ExpenseAmt |
| Grant | $6,558,844 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | RESEARCH: amfAR supports research projects that explore novel approaches to scientifically sound but untested hypotheses in all areas of research on HIV/AIDS, funding goal-oriented studies that often lack the preliminary data required for support from traditional grant makers. The Foundation plays a vital role in HIV/AIDS research, identifying critical gaps in knowledge and providing essential seed money that enables grantees and fellows to test the merits of new concepts or technologies that subsequently can be validated through large-scale studies, such as those funded by the U.S. National Institutes of Health. FOR FURTHER DETAILS, SEE SCHEDULE O. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $5,274,103 | ExpenseAmt |
| Grant | $2,468,525 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | TREAT ASIA: amfAR's TREAT Asia (Therapeutics Research, Education, and AIDS Training in Asia) program is a network of hospitals, clinics, and research institutions working with civil society to ensure the safe and effective delivery of HIV treatments to adults and children across the Asia-Pacific through research, education, and advocacy of evidence-based HIV-related policies. The TREAT Asia Network encompasses 21 adult and 19 pediatric sites throughout the region, which collaborate on a variety of projects. FOR FURTHER DETAILS, SEE SCHEDULE O. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $3,867,810 | ExpenseAmt |
| Grant | $0 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | PUBLIC INFORMATION: amfAR seeks to translate and disseminate information on important AIDS-related research, treatment, prevention, and policy issues for diverse audiences and to increase broad awareness and knowledge of the pandemic. amfAR also publishes a wide range of educational materials, maintains an informative website, and engages respected public figures, HIV/AIDS scientists, and policymakers in communicating the need for continued research to develop new methods of prevention, treatment, and, ultimately, a cure for AIDS. FOR FURTHER DETAILS, SEE SCHEDULE O. | Desc |
Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp (2 entries)
| ExpenseExpenseAmt | GrantGrantAmt | RevenueRevenueAmt | DescDesc |
|---|---|---|---|
| $2,161,783 | $234,816 | $0 | public policy |
| $1,732,068 | $1,087,074 | $0 | GMT Initiative |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Prog Srvc Expense | $3,893,851 | TotalOtherProgSrvcExpenseAmt |
| Total Other Prog Srvc Grant | $1,321,890 | TotalOtherProgSrvcGrantAmt |
| Total Other Prog Srvc Revenue | $0 | TotalOtherProgSrvcRevenueAmt |
| Total Program Service Expenses | $33,248,566 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (true) | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | Yes (true) | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Temp Or Permanent Endowments | Yes (true) | TempOrPermanentEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | false | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | false | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (true) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (true) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | Yes (true) | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | false | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | Yes (true) | ForeignOfficeInd |
| Foreign Activities | Yes (true) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (true) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | Yes (true) | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (true) | FundraisingActivitiesInd |
| Gaming Activities | false | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | Yes (true) | GrantsToOrganizationsInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | false | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | false | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | false | BusinessRlnWithFamMemInd |
| Business Rln With Officer Ent | false | BusinessRlnWithOfficerEntInd |
| Deductible Non Cash Contri | Yes (true) | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | false | DisregardedEntityInd |
| Related Entity | false | RelatedEntityInd |
| Related Organization Ctrl Ent | false | RelatedOrganizationCtrlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 128 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 85 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | false | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | Yes (true) | ForeignFinancialAccountInd |
| Foreign Country | TH | ForeignCountryCd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | Yes (true) | QuidProQuoContributionsInd |
| Quid Pro Quo Contri Discl | Yes (true) | QuidProQuoContriDisclInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 17 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 17 | IndependentVotingMemberCnt |
| Family Or Business Rln | false | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | false | MembersOrStockholdersInd |
| Election Of Board Members | false | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | false | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | false | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | false | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | HI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | LA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ME | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NM | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | BRADLEY JENSEN | PersonNm |
| Phone | 2128061703 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 120 WALL STREET 13TH FLOOR | AddressLine1Txt |
| City | new york | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 100053908 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (40 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|---|
| Mathilde Krim PhD | |||||||||
| Founding Chairman | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| Kenneth Cole | |||||||||
| Chairman of the Board | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| Patricia J Matson | |||||||||
| Vice Chairman | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| John C Simons | |||||||||
| Vice Chairman AND TREASURER | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| Mervyn F Silverman MDMPH | |||||||||
| Secretary | 1.0 | 0.0 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| Arlen H Andelson | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Harry Belafonte | |||||||||
| Trustee (NON-VOTING) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| David Bohnett | |||||||||
| Trustee (NON-VOTING) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Zev Braun | |||||||||
| Trustee (NON-VOTING) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Jonathan S Canno | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Donald Capoccia | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| R Martin Chavez PhD | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Jane B Eisner | |||||||||
| Trustee (NON-VOTING) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| T Ryan Greenawalt | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Regan Hofmann | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Michael J Klingensmith | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Kevin McClatchy | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Michele V McNeill PharmD | |||||||||
| Trustee (NON-VOTING) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Edward Milstein | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Cindy Rachofsky | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Vincent A Roberti | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Bill Roedy | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Raymond F Schinazi PhD | |||||||||
| Trustee | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Alan D Schwartz | |||||||||
| Trustee (NON-VOTING) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Diana L Taylor | |||||||||
| Trustee (NON-VOTING) | 1.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| Kevin Wendle | |||||||||
| Trustee (NON-VOTING) | Yes (X) | $0 | $0 | $0 | |||||
| Kevin Frost | |||||||||
| Chief Executive Officer | 40.0 | 0.0 | Yes (X) | $550,683 | $0 | $93,261 | |||
| Bradley Jensen | |||||||||
| Assistant Treasurer, CFO | 40.0 | 0.0 | Yes (X) | $245,632 | $0 | $56,005 | |||
| John F Logan JD PhD | |||||||||
| AssT Sec, Vp, GEN COUNSEL | 40.0 | 0.0 | Yes (X) | $228,897 | $0 | $28,695 | |||
| Rowena Johnston | |||||||||
| Asst Secretary, Vice President | 40.0 | 0.0 | Yes (X) | $187,484 | $0 | $25,776 | |||
| Edward Donnelly | |||||||||
| Asst Treasurer, Controller | 40.0 | 0.0 | Yes (X) | $151,164 | $0 | $22,555 | |||
| Eric Muscatell | |||||||||
| Vice President of Development | 40.0 | 0.0 | $210,876 | $0 | $27,499 | Yes (X) | |||
| Annette Sohn | |||||||||
| Vice President, TREAT Asia PGM | 40.0 | 0.0 | $226,342 | $0 | $22,332 | Yes (X) | |||
| AnnMarie Shannahan | |||||||||
| Vice President, Public Info. | 40.0 | 0.0 | $216,462 | $0 | $27,806 | Yes (X) | |||
| Gregorio Millet | |||||||||
| Vice President, Public Policy | 40.0 | 0.0 | $180,559 | $0 | $24,932 | Yes (X) | |||
| Andrew McInness | |||||||||
| Director, Publications | 40.0 | 0.0 | $154,961 | $0 | $49,713 | Yes (X) | |||
| Anthony Ancona | |||||||||
| Vice President, Human Resource | 40.0 | 0.0 | $173,915 | $0 | $24,883 | Yes (X) | |||
| Susan Doster | |||||||||
| Chief Technology Officer | 40.0 | 0.0 | $141,709 | $0 | $40,092 | Yes (X) | |||
| Bennah Serfaty | |||||||||
| Sr Director of CommunicatiON | 40.0 | 0.0 | $123,037 | $0 | $47,434 | Yes (X) | |||
| JONATHAN KEY | |||||||||
| DIRECTOR, PHILANTHROPY | 40.0 | 0.0 | $178,219 | $0 | $39,299 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $2,969,940 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $530,282 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 25 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | false | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| AAB PRODUCTION INC | |||||
| 64 ALLEN STREET 5TH FLOOR | NEW YORK | NY | 10002 | events production | $628,096 |
| JOSH WOODS PRODUCTION | |||||
| 39 WEST 14TH STREET SUITE 504 | NEW YORK | NY | 10011 | Events Production | $533,000 |
| SY YARD | |||||
| 25 BROADWAY 2ND FL | NEW YORK | NY | 10004 | MARKETING CONSULTANT | $380,241 |
| EIDOLON COMMUNICATIONS INC | |||||
| 15 MAIDEN LANE SUITE 1401 | NEW YORK | NY | 10038 | DIRECT MAIL/CONSULT. | $273,300 |
| KING COMPANY | |||||
| 101 FIFTH AVENUE 8TH FLOOR | NEW YORK | NY | 10003 | PUBLIC RELATIONS | $208,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 8 | CntrctRcvdGreaterThan100KCnt |
| Federated Campaigns | $267,404 | FederatedCampaignsAmt |
| Fundraising | $33,932,932 | FundraisingAmt |
| Government Grants | $13,063,451 | GovernmentGrantsAmt |
| All Other Contributions | $11,546,419 | AllOtherContributionsAmt |
| Noncash Contributions | $135,714 | NoncashContributionsAmt |
| Total Contributions | $58,810,206 | TotalContributionsAmt |
| Total Program Service Revenue | $0 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $1,300,886 | TotalRevenueColumnAmt |
| Exclusion | $1,300,886 | ExclusionAmt |
Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $15,486 | TotalRevenueColumnAmt |
| Exclusion | $15,486 | ExclusionAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
| Personal | $0 | PersonalAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $9,683,064 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $9,875,116 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | -$192,052 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$192,052 | TotalRevenueColumnAmt |
| Exclusion | -$192,052 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $2,065,725 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $33,932,932 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $13,267,689 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$11,201,964 | TotalRevenueColumnAmt |
| Exclusion | -$11,201,964 | ExclusionAmt |
Net Income From Gaming NetIncomeFromGamingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Sales Of Inventory | $169,839 | GrossSalesOfInventoryAmt |
| Cost Of Goods Sold | $50,720 | CostOfGoodsSoldAmt |
Net Income Or Loss NetIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $119,119 | TotalRevenueColumnAmt |
| Exclusion | $119,119 | ExclusionAmt |
Other Revenue Misc OtherRevenueMiscGrp (3 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | ExclusionExclusionAmt |
|---|---|---|---|
| LIST RENTALS | 900099 | $9,117 | $9,117 |
| STORE SALES | 900099 | $604 | $604 |
| MISCELLANEOUS INCOME | 900099 | $796 | $796 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $10,517 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $48,862,198 | TotalRevenueColumnAmt |
| Exclusion | -$9,948,008 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part IX | Yes (X) | InfoInScheduleOPartIXInd |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,862,816 | TotalAmt |
| Program Services | $5,862,816 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,486,443 | TotalAmt |
| Program Services | $4,486,443 | ProgramServicesAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,648,073 | TotalAmt |
| Program Services | $1,927,273 | ProgramServicesAmt |
| Management And General | $343,609 | ManagementAndGeneralAmt |
| Fundraising | $377,191 | FundraisingAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,613,504 | TotalAmt |
| Program Services | $3,707,639 | ProgramServicesAmt |
| Management And General | $612,539 | ManagementAndGeneralAmt |
| Fundraising | $1,293,326 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $340,688 | TotalAmt |
| Program Services | $223,192 | ProgramServicesAmt |
| Management And General | $40,527 | ManagementAndGeneralAmt |
| Fundraising | $76,969 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,385,492 | TotalAmt |
| Program Services | $903,861 | ProgramServicesAmt |
| Management And General | $202,309 | ManagementAndGeneralAmt |
| Fundraising | $279,322 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $500,013 | TotalAmt |
| Program Services | $324,470 | ProgramServicesAmt |
| Management And General | $61,337 | ManagementAndGeneralAmt |
| Fundraising | $114,206 | FundraisingAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $155,687 | TotalAmt |
| Program Services | $148,384 | ProgramServicesAmt |
| Management And General | $5,736 | ManagementAndGeneralAmt |
| Fundraising | $1,567 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $189,003 | TotalAmt |
| Management And General | $189,003 | ManagementAndGeneralAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $95,320 | TotalAmt |
| Program Services | $95,320 | ProgramServicesAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $854,723 | TotalAmt |
| Fundraising | $854,723 | FundraisingAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $265,339 | TotalAmt |
| Management And General | $265,339 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,960,502 | TotalAmt |
| Program Services | $1,400,385 | ProgramServicesAmt |
| Management And General | $74,386 | ManagementAndGeneralAmt |
| Fundraising | $485,731 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $258,250 | TotalAmt |
| Program Services | $241,080 | ProgramServicesAmt |
| Management And General | $1,621 | ManagementAndGeneralAmt |
| Fundraising | $15,549 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $76,737 | TotalAmt |
| Program Services | $46,214 | ProgramServicesAmt |
| Management And General | $6,340 | ManagementAndGeneralAmt |
| Fundraising | $24,183 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $293,765 | TotalAmt |
| Program Services | $225,841 | ProgramServicesAmt |
| Management And General | $31,251 | ManagementAndGeneralAmt |
| Fundraising | $36,673 | FundraisingAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,280,442 | TotalAmt |
| Program Services | $969,575 | ProgramServicesAmt |
| Management And General | $127,879 | ManagementAndGeneralAmt |
| Fundraising | $182,988 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,191,577 | TotalAmt |
| Program Services | $526,831 | ProgramServicesAmt |
| Management And General | $2,892 | ManagementAndGeneralAmt |
| Fundraising | $661,854 | FundraisingAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $732,011 | TotalAmt |
| Program Services | $651,535 | ProgramServicesAmt |
| Management And General | $10,086 | ManagementAndGeneralAmt |
| Fundraising | $70,390 | FundraisingAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $38 | TotalAmt |
| Management And General | $38 | ManagementAndGeneralAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $462,556 | TotalAmt |
| Program Services | $352,712 | ProgramServicesAmt |
| Management And General | $46,520 | ManagementAndGeneralAmt |
| Fundraising | $63,324 | FundraisingAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $315,054 | TotalAmt |
| Program Services | $240,238 | ProgramServicesAmt |
| Management And General | $31,685 | ManagementAndGeneralAmt |
| Fundraising | $43,131 | FundraisingAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| PROGRAM MATERIALS | $8,449,443 | $8,449,443 | ||
| POSTAGE & SHIPPING | $996,058 | $996,058 | ||
| PRINTING | $815,503 | $236,989 | $407 | $578,107 |
| PROGRAM TECHNICAL SUPPORT | $711,501 | $314,466 | $3,164 | $393,871 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,736,770 | TotalAmt |
| Program Services | $917,801 | ProgramServicesAmt |
| Management And General | $453,313 | ManagementAndGeneralAmt |
| Fundraising | $365,656 | FundraisingAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $41,677,308 | TotalAmt |
| Program Services | $33,248,566 | ProgramServicesAmt |
| Management And General | $2,509,981 | ManagementAndGeneralAmt |
| Fundraising | $5,918,761 | FundraisingAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Joint Costs | Yes (X) | JointCostsInd |
Total Joint Costs TotalJointCostsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $887,518 | TotalAmt |
| Program Services | $272,421 | ProgramServicesAmt |
| Fundraising | $615,097 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $18,387,580 | BOYAmt |
| EOY | $21,651,323 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $323,338 | BOYAmt |
| EOY | $323,338 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $369,693 | BOYAmt |
| EOY | $464,693 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $6,118,590 | BOYAmt |
| EOY | $9,959,486 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $191,382 | BOYAmt |
| EOY | $575,913 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,480,222 | BOYAmt |
| EOY | $1,630,566 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $6,869,229 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $3,892,663 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,288,934 | BOYAmt |
| EOY | $2,976,566 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $39,666,715 | BOYAmt |
| EOY | $42,064,454 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,069,137 | BOYAmt |
| EOY | $36,797 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,355,502 | BOYAmt |
| EOY | $1,090,525 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $71,251,093 | BOYAmt |
| EOY | $80,773,661 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,435,700 | BOYAmt |
| EOY | $3,412,592 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,049,552 | BOYAmt |
| EOY | $2,973,966 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $10,067,061 | BOYAmt |
| EOY | $10,727,662 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,660,158 | BOYAmt |
| EOY | $2,020,261 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $18,212,471 | BOYAmt |
| EOY | $19,134,481 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows SFAS117 | Yes (X) | OrganizationFollowsSFAS117Ind |
Unrestricted Net Assets UnrestrictedNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $48,874,571 | BOYAmt |
| EOY | $58,215,899 | EOYAmt |
Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,808,811 | BOYAmt |
| EOY | $3,060,748 | EOYAmt |
Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $355,240 | BOYAmt |
| EOY | $362,533 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $53,038,622 | BOYAmt |
| EOY | $61,639,180 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $71,251,093 | BOYAmt |
| EOY | $80,773,661 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | $7,184,890 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $1,413,485 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $2,183 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Separate Basis Fincl Stmt | Yes (X) | SeparateBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (true) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (true) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $33,247,849 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $38,582,579 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $57,556,516 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $56,251,128 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $58,810,206 | CurrentTaxYearAmt |
| Total | $244,448,278 | TotalAmt |
Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $33,247,849 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $38,582,579 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $57,556,516 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $56,251,128 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $58,810,206 | CurrentTaxYearAmt |
| Total | $244,448,278 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $6,057,646 | SubstantialContributorsTotAmt |
| Public Support Total170 | $238,390,632 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $897,974 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $755,293 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $804,366 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $1,652,775 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $1,316,372 | CurrentTaxYearAmt |
| Total | $5,426,780 | TotalAmt |
Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $1,624,966 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $1,467,184 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $1,693,833 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $2,103,589 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $2,246,081 | CurrentTaxYearAmt |
| Total | $9,135,653 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $259,010,711 | TotalSupportAmt |
| Public Support CY170 | 0.92039 | PublicSupportCY170Pct |
| Public Support PY170 | 0.92323 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Grassroots Lobbying | TotalGrassrootsLobbyingGrp | |
| Total Direct Lobbying | TotalDirectLobbyingGrp | |
| Total Lobbying Expend | TotalLobbyingExpendGrp | |
| Other Exempt Purpose Expend | OtherExemptPurposeExpendGrp | |
| Total Exempt Purpose Expend | TotalExemptPurposeExpendGrp | |
| Lobbying Nontaxable Amount | LobbyingNontaxableAmountGrp | |
| Grassroots Nontaxable | GrassrootsNontaxableGrp | |
| Tot Lbbyng Grassroot Mns Non Tx | TotLbbyngGrassrootMnsNonTxGrp | |
| Tot Lbby Expend Mns Lbbyng Non Tx | TotLbbyExpendMnsLbbyngNonTxGrp | |
| Volunteers | false | VolunteersInd |
| Paid Staff Or Management | Yes (true) | PaidStaffOrManagementInd |
| Media Advertisements | false | MediaAdvertisementsInd |
| Mailings Members | false | MailingsMembersInd |
| Publications Or Broadcast | false | PublicationsOrBroadcastInd |
| Grants Other Organizations | false | GrantsOtherOrganizationsInd |
| Direct Contact Legislators | false | DirectContactLegislatorsInd |
| Rallies Demonstrations | false | RalliesDemonstrationsInd |
| Other Activities | Yes (true) | OtherActivitiesInd |
| Other Activities | $268,477 | OtherActivitiesAmt |
| Total Lobbying Expenditures | $268,477 | TotalLobbyingExpendituresAmt |
| Not Described Section501c3 | false | NotDescribedSection501c3Ind |
| Form4720 Filed4912 Tax | false | Form4720Filed4912TaxInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Lobbying Expenses | FormAndLineReferenceDesc |
| Explanation | Part II-B The Foundation for AIDS Research developed an Action Agenda to End AIDS that identified critical decisions that need to be made to advance evidence based AIDS policies. We created a variety of issue briefs on topics such as the potential impact of various budget scenarios on global health services, and policy priorities to address the HIV epidemic among gay men in the US. These issue briefs were shared with Capitol Hill staff and members of the Administration. amfAR met regularly with staff to members of Congress and with Administration staff, and we provided input to the Administration on development of the PEPFAR Blueprint for an AIDS Free Generation. amfAR sponsored several briefings on Capitol Hill on AIDS policy and research issues. amfAR uses these briefings as an educational tool. | ExplanationTxt |
Schedule D IRS990ScheduleD
Art Public Exhibition Amounts ArtPublicExhibitionAmountsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Assets Included | $640,959 | AssetsIncludedAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Held Works Art | HeldWorksArtGrp |
Collection Used Other Purposes CollectionUsedOtherPurposesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Collection Used Other Purposes | Yes (X) | CollectionUsedOtherPurposesInd |
| Other Purposes | Donated Items, Inventory etc. | OtherPurposesDesc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Solicited Assets Sale | Yes (true) | SolicitedAssetsSaleInd |
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $493,036 | BeginningYearBalanceAmt |
| Contributions | $7,293 | ContributionsAmt |
| Investment Earnings Or Losses | $40,902 | InvestmentEarningsOrLossesAmt |
| End Year Balance | $541,231 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $490,979 | BeginningYearBalanceAmt |
| Contributions | $7,998 | ContributionsAmt |
| Investment Earnings Or Losses | -$5,941 | InvestmentEarningsOrLossesAmt |
| End Year Balance | $493,036 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $443,886 | BeginningYearBalanceAmt |
| Contributions | $6,543 | ContributionsAmt |
| Investment Earnings Or Losses | $40,550 | InvestmentEarningsOrLossesAmt |
| End Year Balance | $490,979 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $520,804 | BeginningYearBalanceAmt |
| Contributions | $3,211 | ContributionsAmt |
| Investment Earnings Or Losses | $20,742 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $100,871 | OtherExpendituresAmt |
| End Year Balance | $443,886 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $464,356 | BeginningYearBalanceAmt |
| Contributions | $4,341 | ContributionsAmt |
| Investment Earnings Or Losses | $52,107 | InvestmentEarningsOrLossesAmt |
| End Year Balance | $520,804 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prmnnt Endowment Balance EOY | 0.66980 | PrmnntEndowmentBalanceEOYPct |
| Term Endowment Balance EOY | 0.33020 | TermEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | false | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | false | EndowmentsHeldRelatedOrgInd |
| Land | LandGrp | |
| Buildings | BuildingsGrp |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $2,542,490 | OtherCostOrOtherBasisAmt |
| Depreciation | $1,010,836 | DepreciationAmt |
| Book Value | $1,531,654 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $304,196 | OtherCostOrOtherBasisAmt |
| Depreciation | $288,027 | DepreciationAmt |
| Book Value | $16,169 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $4,022,543 | OtherCostOrOtherBasisAmt |
| Depreciation | $2,593,800 | DepreciationAmt |
| Book Value | $1,428,743 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $2,976,566 | TotalBookValueLandBuildingsAmt |
| Federal Income Tax Liability | $0 | FederalIncomeTaxLiabilityAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)
| DescDesc | AmtAmt |
|---|---|
| LONG TERM LEASE LIABILITY | $1,838,533 |
| SECTION 457 RETIREMENT LIABILITY | $181,728 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $2,020,261 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $50,539,089 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | $1,413,485 | NetUnrealizedGainsInvstAmt |
| Donated Services And Use Fclts | $261,223 | DonatedServicesAndUseFcltsAmt |
| Other Revenue | $2,183 | OtherRevenueAmt |
| Revenue Not Reported | $1,676,891 | RevenueNotReportedAmt |
| Revenue Subtotal | $48,862,198 | RevenueSubtotalAmt |
| Total Revenue Per Form990 | $48,862,198 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $41,938,531 | TotExpnsEtcAuditedFinclStmtAmt |
| Donated Services Use Fclts | $261,223 | DonatedServicesUseFcltsAmt |
| Expenses Not Reported | $261,223 | ExpensesNotReportedAmt |
| Expenses Subtotal | $41,677,308 | ExpensesSubtotalAmt |
| Total Expenses Per Form990 | $41,677,308 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (4 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Endowments | Part V, Line 4 AMFAR's endowment fund is intended to fund the various general research programs the organization sponsors. |
| FIN 48 - Income taxes | Amfar follows guidance that clarifies the accounting for uncertainty in tax positions taken or expected to be taken in a tax return, including issues relating to financial statement recognition and guidance on measurement. This guidance provides that the tax effects from an uncertain tax position can only be recognized in the financial statements if the position is "more-likely-than-not" to be sustained if the position were to be challenged by a taxing authority. The assessment of the tax position is based solely on the technical merits of the position, without regard to the likelihood that the tax position may be challenged. Amfar has processes presently in place to ensure the maintenance of its tax-exempt status; to identify and report unrelated income; to determine its filing and tax obligations in jurisdictions for which it has nexus; and to identify and evaluate other matters that may be considered tax positions. The tax years ended SEPTEMBER 30, 2013, 2014, 2015 and 2016 are still open to audit for both federal and state purposes. amfAR has determined that there are no material uncertain tax positions that require recognition or disclosure in the financial statements. |
| Collections of Art, Historical Treasures, or other similar assets | Part III, Line 4 AMFAR holds various items of jewelry, photographs and other items of artistic value that have been donated to the organization for sale at special events. The organization has maintained these items in inventory for a few years and is in the process of selling them. |
| schedule d, part XI line 2d | Change in beneficial interest $2,183 |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (10 entries)
| RegionRegionTxt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt | OfficesOfficesCnt | EmployeeEmployeeCnt |
|---|---|---|---|---|---|
| Central America and the Caribbean | Grantmaking | N/A | $25,000 | ||
| East Asia and the Pacific | Grantmaking | N/A | $3,214,551 | ||
| Europe (Including Iceland and Greenland) | Grantmaking | n/a | $876,995 | ||
| South America | Grantmaking | N/A | $233,783 | ||
| South Asia | Grantmaking | N/A | $106,248 | ||
| Sub-Saharan Africa | Grantmaking | N/A | $29,866 | ||
| East Asia and the Pacific | Program Services | THERAPEUTICS,TRAINING | $1,899,975 | 1 | 16 |
| Europe (Including Iceland and Greenland) | Fundraising | N/A | $10,574,889 | ||
| South America | Fundraising | N/A | $803,335 | ||
| South Asia | Fundraising | N/A | $1,998,100 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 1 | SubtotalOfficesCnt |
| Subtotal Employees | 16 | SubtotalEmployeesCnt |
| Total Office | 1 | TotalOfficeCnt |
| Total Employee | 16 | TotalEmployeeCnt |
| Subtotal Spent | $19,762,742 | SubtotalSpentAmt |
| Total Spent | $19,762,742 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (106 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt |
|---|---|---|---|
| Central America and the Caribbean | GMT INITIATIVE | $25,000 | wire transfe |
| East Asia and the Pacific | BASIC RESEARCH | $70,860 | wire transfe |
| East Asia and the Pacific | BASIC RESEARCH | $499,976 | wire transfe |
| East Asia and the Pacific | BASIC RESEARCH | $169,134 | wire transfe |
| East Asia and the Pacific | GMT INITIATIVE | $184,612 | wire transfe |
| East Asia and the Pacific | GMT INITIATIVE | $159,255 | wire transfe |
| East Asia and the Pacific | GMT INITIATIVE | $25,000 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $11,648 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $19,234 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $5,680 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $8,310 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $8,100 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $80,408 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $5,703 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $7,500 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $14,997 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $6,250 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $19,950 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $8,740 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $19,748 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $15,450 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $15,600 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $11,250 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $20,656 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $16,000 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $15,460 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $21,781 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $22,604 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $21,506 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $24,158 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $21,586 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $22,338 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $21,368 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $14,250 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $20,774 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $20,224 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $21,250 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $5,250 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $6,750 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $5,925 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $5,850 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $5,250 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $5,925 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $15,000 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $319,000 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $166,780 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $50,710 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $93,567 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $8,000 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $183,396 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $48,023 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $36,345 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $46,270 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $7,270 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $7,425 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $16,537 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $21,127 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $14,784 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $37,733 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $10,814 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $14,996 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $12,621 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $21,600 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $7,021 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $11,603 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $7,581 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $11,421 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $9,023 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $8,550 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $24,013 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $15,000 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $7,992 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $7,555 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $35,020 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $9,928 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $5,625 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $5,625 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $5,625 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $5,625 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $11,250 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $11,250 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $11,250 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $11,250 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $15,000 | wire transfe |
| East Asia/Pacific | TREAT ASIA | $15,000 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $30,000 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $19,142 | wire transfe |
| East Asia and the Pacific | TREAT ASIA | $7,008 | wire transfe |
| Europe (Including Iceland and Greenland) | BASIC RESEARCH | $89,971 | wire transfe |
| Europe (Including Iceland and Greenland) | BASIC RESEARCH | $6,234 | wire transfe |
| Europe (Including Iceland and Greenland) | BASIC RESEARCH | $40,000 | wire transfe |
| Europe (Including Iceland and Greenland) | BASIC RESEARCH | $46,809 | wire transfe |
| Europe (Including Iceland and Greenland) | BASIC RESEARCH | $26,668 | wire transfe |
| Europe (Including Iceland and Greenland) | BASIC RESEARCH | $29,167 | wire transfe |
| Europe (Including Iceland and Greenland) | RESEARCH | $667,769 | wire transfe |
| Europe (Including Iceland and Greenland) | RESEARCH | $127,700 | wire transfe |
| South America | GMT INITIATIVE | $233,783 | wire transfe |
| South Asia | GMT INITIATIVE | $25,000 | wire transfe |
| South Asia | PUBLIC POLICY | $30,000 | wire transfe |
| South Asia | TREAT ASIA | $7,500 | wire transfe |
| South Asia | TREAT ASIA | $19,104 | wire transfe |
| South Asia | TREAT ASIA | $10,060 | wire transfe |
| South Asia | TREAT ASIA | $6,500 | wire transfe |
| South Asia | TREAT ASIA | $7,001 | wire transfe |
| South Asia | TREAT ASIA | $6,583 | wire transfe |
| Sub-Saharan Africa | GMT INITIATIVE | $25,000 | wire transfe |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 110 | Total501c3OrgCnt |
| Transfer To Foreign Corp | false | TransferToForeignCorpInd |
| Interest In Foreign Trust | false | InterestInForeignTrustInd |
| Foreign Corp Ownership | false | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | false | PassiveForeignInvestmestCoInd |
| Foreign Partnership | false | ForeignPartnershipInd |
| Boycott Countries | false | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Foreign Activities | Part I, Line 2 International organizations are recommended for funding based upon the results of community-based peer review and/or program staff assessment of proposal merit and organization capacity to undertake proposed projects that are CHARITABLE in purpose. Pre-award due-diligence for new international grantees includes review of organization documents and registrations to verify that the organization operates for a CHARITABLE purpose and that basic capacity for project oversight and governance has been established. All international grantees are required to report semi-annually on project progress and expenditures; continued reporting is required until such time as grant funds are expended in full. Reports are reviewed by administrative and program staff. Additional oversight is provided as necessary by means of ongoing, informal contact with sites regarding progress and technical issues and site visits where feasible. International research grant recipients submit an interim and a final progress reporting addition to expenditures reports due following the ends of the 2nd, 3rd and final quarters of the performance period. |
| foreign activities | Part I, Line 3, Column D The Foundation for AIDS Research conducts many of its grant-making program services (see Part III of Form 990) in U.S. and foreign jurisdictions. In column D, the organization has reported the basic program these grants support; please refer to Part III for more information about these programs/initiatives. |
| Foreign Activities - Status of Grantees | The Foundation for Aids Research supports many non-U.S. organizations in the fight against AIDS and HIV-related diseases. For purposes of Schedule F, Part II, Line 2 - all 110 charities supported are presumed to be the equivalent of U.S. charities. |
Schedule G IRS990ScheduleG
| Field | Value | IRS element (for citing) |
|---|---|---|
| Mail Solicitations | Yes (X) | MailSolicitationsInd |
| Email Solicitations | Yes (X) | EmailSolicitationsInd |
| Phone Solicitations | Yes (X) | PhoneSolicitationsInd |
| Solicitation Of Non Govt Grants | Yes (X) | SolicitationOfNonGovtGrantsInd |
| Solicitation Of Govt Grants | Yes (X) | SolicitationOfGovtGrantsInd |
| Special Fundraising Events | Yes (X) | SpecialFundraisingEventsInd |
| Agrmt Prof Fundraising Acty | Yes (true) | AgrmtProfFundraisingActyInd |
Fundraiser Activity Info FundraiserActivityInfoGrp (4 entries)
| ActivityActivityTxt | Fundraiser Control Of FundsFundraiserControlOfFundsInd | Gross ReceiptsGrossReceiptsAmt | Retained By ContractorRetainedByContractorAmt | Net To OrganizationNetToOrganizationAmt |
|---|---|---|---|---|
| aab productions INC | ||||
| events production | false | $26,721,994 | $515,250 | $26,206,744 |
| EIDOLON COMMUNICATIONS INC | ||||
| direct mail | false | $2,170,244 | $308,509 | $1,861,735 |
| Donor Services Group LLC | ||||
| Tele marketing | false | $24,717 | $54,964 | -$30,247 |
| Josh Woods Production | ||||
| Special event prod. | false | $7,199,671 | $427,500 | $6,772,171 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Gross Receipts | $36,116,626 | TotalGrossReceiptsAmt |
| Total Retained By Contractors | $1,306,223 | TotalRetainedByContractorsAmt |
| Total Net To Organization | $34,810,403 | TotalNetToOrganizationAmt |
| Licensed States | AL | LicensedStatesCd |
| Licensed States | AK | LicensedStatesCd |
| Licensed States | AR | LicensedStatesCd |
| Licensed States | CA | LicensedStatesCd |
| Licensed States | CO | LicensedStatesCd |
| Licensed States | CT | LicensedStatesCd |
| Licensed States | DC | LicensedStatesCd |
| Licensed States | FL | LicensedStatesCd |
| Licensed States | GA | LicensedStatesCd |
| Licensed States | HI | LicensedStatesCd |
| Licensed States | IL | LicensedStatesCd |
| Licensed States | KS | LicensedStatesCd |
| Licensed States | KY | LicensedStatesCd |
| Licensed States | LA | LicensedStatesCd |
| Licensed States | ME | LicensedStatesCd |
| Licensed States | MD | LicensedStatesCd |
| Licensed States | MA | LicensedStatesCd |
| Licensed States | MI | LicensedStatesCd |
| Licensed States | MN | LicensedStatesCd |
| Licensed States | MS | LicensedStatesCd |
| Licensed States | MO | LicensedStatesCd |
| Licensed States | NV | LicensedStatesCd |
| Licensed States | NH | LicensedStatesCd |
| Licensed States | NJ | LicensedStatesCd |
| Licensed States | NM | LicensedStatesCd |
| Licensed States | NY | LicensedStatesCd |
| Licensed States | NC | LicensedStatesCd |
| Licensed States | ND | LicensedStatesCd |
| Licensed States | OH | LicensedStatesCd |
| Licensed States | OK | LicensedStatesCd |
| Licensed States | OR | LicensedStatesCd |
| Licensed States | PA | LicensedStatesCd |
| Licensed States | RI | LicensedStatesCd |
| Licensed States | SC | LicensedStatesCd |
| Licensed States | TN | LicensedStatesCd |
| Licensed States | TX | LicensedStatesCd |
| Licensed States | UT | LicensedStatesCd |
| Licensed States | VA | LicensedStatesCd |
| Licensed States | WA | LicensedStatesCd |
| Licensed States | WV | LicensedStatesCd |
| Licensed States | WI | LicensedStatesCd |
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | CANNES | Event1Nm |
| Gross Receipts Event1 | $15,196,962 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $14,695,962 | CharitableContriEvent1Amt |
| Gross Revenue Event1 | $501,000 | GrossRevenueEvent1Amt |
| Rent Facility Costs Event1 | $1,083,589 | RentFacilityCostsEvent1Amt |
| Food And Beverage Event1 | $374,402 | FoodAndBeverageEvent1Amt |
| Entertainment Event1 | $1,817,077 | EntertainmentEvent1Amt |
| Other Direct Expenses Event1 | $3,569,976 | OtherDirectExpensesEvent1Amt |
| Event2 | DALLAS | Event2Nm |
| Gross Receipts Event2 | $5,011,152 | GrossReceiptsEvent2Amt |
| Charitable Contri Event2 | $4,857,027 | CharitableContriEvent2Amt |
| Gross Revenue Event2 | $154,125 | GrossRevenueEvent2Amt |
| Rent Facility Costs Event2 | $340,618 | RentFacilityCostsEvent2Amt |
| Food And Beverage Event2 | $177,719 | FoodAndBeverageEvent2Amt |
| Entertainment Event2 | $155,996 | EntertainmentEvent2Amt |
| Other Direct Expenses Event2 | $506,256 | OtherDirectExpensesEvent2Amt |
| Other Events Total | 18 | OtherEventsTotalCnt |
| Gross Receipts Other Events | $15,790,543 | GrossReceiptsOtherEventsAmt |
| Charitable Contri Other Events | $14,379,943 | CharitableContriOtherEventsAmt |
| Gross Revenue Other Events | $1,410,600 | GrossRevenueOtherEventsAmt |
| Rent Fclty Costs Other Events | $665,398 | RentFcltyCostsOtherEventsAmt |
| Food And Beverage Other Events | $1,039,513 | FoodAndBeverageOtherEventsAmt |
| Entertainment Other Events | $1,611,869 | EntertainmentOtherEventsAmt |
| Oth Direct Expnss Other Events | $2,051,801 | OthDirectExpnssOtherEventsAmt |
| Gross Receipts Total | $35,998,657 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $33,932,932 | CharitableContributionsTotAmt |
| Gross Revenue Total Events | $2,065,725 | GrossRevenueTotalEventsAmt |
| Rent Fclty Costs Total Events | $2,089,605 | RentFcltyCostsTotalEventsAmt |
| Food And Beverage Total Events | $1,591,634 | FoodAndBeverageTotalEventsAmt |
| Entertainment Total Events | $3,584,942 | EntertainmentTotalEventsAmt |
| Oth Direct Expnss Total Events | $6,128,033 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $13,394,214 | DirectExpenseSummaryEventsAmt |
| Net Income Summary | -$11,328,489 | NetIncomeSummaryAmt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Schedule G, Part I | FormAndLineReferenceDesc |
| Explanation | The Foundation for AIDS Research actually paid out $854,723 in fundraising expenses for the year ending September 30, 2016. This amount is reported on Part IX, Line 11(e). For purposes of Schedule G, the Foundation is reporting all amounts paid to the consultants listed on Part I, regardless of whether such amounts were pure fundraising expenses or event production costs. On Schedule G, the total amount paid to the organizations listed is $1,306,223. Of that $1,306,223, only $854,723 was paid for fundraising services, the remaining $451,500 was paid for event production services. In the interests of clarity, the foundation would also like to make clear that the compensation reported as having been paid to the professional fundraisers reported on Schedule G is reported on a fiscal year basis. Some of those same fundraisers are reported on the foundation's top 5 highest paid independent contractors list (in Schedule O). In compliance with the instructions to the Form 990, compensation reported for Part VII (and listed in Schedule O) is reported on a calendar year basis. Accordingly, amounts on Part VII and Schedule G will not reconcile. | ExplanationTxt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (45 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|
| Emory University | |||||||
| 1599 Clifton Rd | Atlanta | GA | 303224250 | 580566256 | 501(c)(3) | $18,000 | BASIC RESEARCH |
| Icahn School of Medicine | |||||||
| One Gustave Levy Place | New York | NY | 10029 | 136171197 | 501(c)(3) | $30,000 | BASIC RESEARCH |
| The Rockefeller University | |||||||
| 1230 York Avenue | New York | NY | 10065 | 131624158 | 501(c)(3) | $75,000 | BASIC RESEARCH |
| New York University | |||||||
| 545 1st Ave | New York | NY | 10016 | 135562308 | 501(c)(3) | $44,997 | BASIC RESEARCH |
| Trustees of the University of PA | |||||||
| 422 Curie Blvd | Philadelphia | PA | 19104 | 231352685 | 501(c)(3) | $50,000 | BASIC RESEARCH |
| Johns Hopkins University | |||||||
| 733 N Broadway | Baltimore | MD | 21205 | 520595110 | 501(c)(3) | $245,424 | GMT INITIATIVE |
| University of Washington | |||||||
| 4333 Brooklyn Ave | Seattle | WA | 981959472 | 916001537 | 501(c)(3) | $90,000 | BASIC RESEARCH |
| Oregon Health & Science Uni | |||||||
| 3181 Sam Jackson Pk Rd | Portland | OR | 97239 | 931176109 | 501(c)(3) | $89,911 | BASIC RESEARCH |
| Emory University | |||||||
| 1599 Clifton Rd | Atlanta | GA | 303224250 | 580566256 | 501(c)(3) | $90,000 | BASIC RESEARCH |
| Blood Systems Inc | |||||||
| 270 Masonic Ave | San Francisco | CA | 94118 | 860098929 | 501(c)(3) | $90,000 | BASIC RESEARCH |
| University of Utah | |||||||
| 15 N Medical Dr | Salt Lake City | UT | 84112 | 876000525 | 501(c)(3) | $90,000 | BASIC RESEARCH |
| Regents of the University of CA | |||||||
| 3333 CA St Ste 315 | San Francisco | CA | 94143 | 946036493 | 501(c)(3) | $51,426 | BASIC RESEARCH |
| University of Nebraska-Lincoln | |||||||
| 151 Whittier RC | Lincoln | NE | 68583 | 470049123 | 501(c)(3) | $90,000 | BASIC RESEARCH |
| Charities Aid Fdn of America | |||||||
| 1800 Diagonal Rd | Alexandria | VA | 22314 | 431634280 | 501(c)(3) | $224,260 | PREVENTION SCIENCE OUTREACH |
| The Rockefeller University | |||||||
| 1230 York Ave | New York | NY | 10065 | 131624158 | 501(c)(3) | $375,000 | BASIC RESEARCH |
| Johns Hopkins University | |||||||
| 733 N Broadway | Baltimore | MD | 21205 | 520595110 | 501(c)(3) | $180,869 | TREAT ASIA |
| Beth Israel Deaconess Medical Center | |||||||
| 330 Brookline Avenue | Boston | MA | 02215 | 042103881 | 501(c)(3) | $497,988 | BASIC RESEARCH |
| Regents of the University of CA | |||||||
| 3333 CA St Ste 315 | San Francisco | CA | 94143 | 946036493 | 501(c)(3) | $500,004 | BASIC RESEARCH |
| Boston Medical Center | |||||||
| One Boston Medical Center | Boston | MA | 02118 | 043314093 | 501(c)(3) | $68,750 | BASIC RESEARCH |
| Yale University | |||||||
| 266 Whitney Ave | New Haven | CT | 06511 | 060646973 | 501(c)(3) | $75,000 | BASIC RESEARCH |
| Fred Hutchinson Cancer Research Center | |||||||
| 1100 Fairview Ave N | Seattle | WA | 98109 | 237156071 | 501(c)(3) | $67,298 | BASIC RESEARCH |
| Dana-Farber Cancer Institute | |||||||
| 44 Binney Street | Boston | MA | 02115 | 042263040 | 501(c)(3) | $38,737 | BASIC RESEARCH |
| University of CA San Francisco | |||||||
| 3333 CA St Ste 315 | San Francisco | CA | 94143 | 946036493 | 501(c)(3) | $1,778,200 | RESEARCH |
| Johns Hopkins University | |||||||
| 733 N Broadway | Baltimore | MD | 21205 | 520595110 | 501(c)(3) | $40,000 | PUBLIC POLICY |
| The George Washington University | |||||||
| 2121 I Street | Washington | DC | 20052 | 530196584 | 501(c)(3) | $89,992 | BASIC RESEARCH |
| Harvard University | |||||||
| 29 Oxford Street | Cambridge | MA | 02138 | 042103580 | 501(c)(3) | $128,438 | RESEARCH |
| New Hope for Cambodian Children | |||||||
| PO Box 690597 | Killeen | TX | 76549 | 205301015 | 501(c)(3) | $20,743 | TREAT ASIA |
| University of California San Diego | |||||||
| 9500 Gilman Drive | San Diego | CA | 920930679 | 956006144 | 501(c)(3) | $66,665 | BASIC RESEARCH |
| Case Western Reserve University | |||||||
| 10900 Euclid Avenue | Cleveland | OH | 44106 | 341018992 | 501(c)(3) | $66,665 | BASIC RESEARCH |
| Case Western Reserve University | |||||||
| 10900 Euclid Avenue | Cleveland | OH | 44106 | 341018992 | 501(c)(3) | $66,665 | BASIC RESEARCH |
| Emory University | |||||||
| 1599 Clifton Rd | Atlanta | GA | 303224250 | 580566256 | 501(c)(3) | $66,665 | BASIC RESEARCH |
| Emory University | |||||||
| 1599 Clifton Road | Atlanta | GA | 303224250 | 580566256 | 501(c)(3) | $66,665 | BASIC RESEARCH |
| Johns Hopkins University | |||||||
| 733 N Broadway | Baltimore | MD | 21205 | 520595110 | 501(c)(3) | $66,665 | BASIC RESEARCH |
| Massachusetts General Hospital | |||||||
| 101 Huntington Ave | Boston | MA | 02199 | 042697983 | 501(c)(3) | $59,951 | TREAT ASIA |
| University of Pittsburgh | |||||||
| 123 University Place | Pittsburgh | PA | 15213 | 250965591 | 501(c)(3) | $164,000 | GMT INITIATIVE |
| Regents of the University of CA | |||||||
| 3333 CA St Ste 315 | San Francisco | CA | 94143 | 946036493 | 501(c)(3) | $51,842 | BASIC RESEARCH |
| New Hope for Cambodian Children | |||||||
| PO Box 690597 | Killee | TX | 76549 | 205301015 | 501(c)(3) | $50,000 | TREAT ASIA |
| Infectious Disease Research Inst | |||||||
| 1616 Eastlake Ave | Seattle | WA | 98102 | 911608978 | 501(c)(3) | $35,000 | BASIC RESEARCH |
| University of Illinois at Chicago | |||||||
| 809 S Marshfield Ave | Chicago | IL | 60612 | 376000511 | 501(c)(3) | $56,050 | BASIC RESEARCH |
| Regents of the University of MN | |||||||
| 200 Oak St Ste 450 | Minneapolis | MN | 55455 | 416007513 | 501(c)(3) | $59,031 | RESEARCH |
| The Rockefeller University | |||||||
| 1230 York Avenue | New York | NY | 10065 | 131624158 | 501(c)(3) | $20,000 | BASIC RESEARCH |
| Georgetown University | |||||||
| 600 New Jersey Avenue | Washington | DC | 20057 | 530196603 | 501(c)(3) | $99,350 | PUBLIC POLICY |
| AIDS Vaccine Advocacy Coalition | |||||||
| 423 West 127 St 4th Fl | New York | NY | 10027 | 943240841 | 501(c)(3) | $50,600 | PUBLIC POLICY |
| Project Inform | |||||||
| 1375 Mission Street | San Francisco | CA | 94103 | 943052723 | 501(c)(3) | $10,000 | PUBLIC POLICY |
| Columbia University | |||||||
| 630 W 168th St Box 49 | New York | NY | 10032 | 135598093 | 501(c)(3) | $500,000 | PREVENTION SCIENCE OUTREACH |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 45 | Total501c3OrgCnt |
| Total Other Org | 0 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Grants and Assistance | FormAndLineReferenceDesc |
| Explanation | Part I, Line 2 amfAR Provides grants and fellowships to independent not-for-profit organizations through a peer-review process. Grant applications are first reviewed by the Foundation's volunteer scientific advisory committee, which comprises recognized experts in the medical, scientific, and social sciences disciplines relevant to HIV and AIDS. The scientific advisory committee then sends its evaluations to one of the three committees (research, global initiatives or public policy) of the Foundation's program board, which serves in an advisory capacity to the Board of Trustees. After a program committee has completed its review of the applications, it presents its funding recommendations to amfAR's executive committee and/or the full Board of Trustees for final approval and funding authorization. Grants and fellowships are payable over a one-to-three-year period, and are revocable at amfAR's option if the recipient's performance or use of funds is not consistent with the terms of the grant or fellowships. In certain cases, the actual amounts paid under grants and fellowship awards may be less than the original award if the recipient does not use the full amount awarded. Therefore, a reserve for unexpended grants and fellowships has been recorded. Subawards are grants awarded to not-for-profit organizations to support the costs of collaboration and participation in HIV/AIDS-related research projects for which amfAR has secured restricted funds. Subawards are payable over a one-year period, although advance payments, in full or in part, may be issued following execution of the subaward agreement. Subawards are contingent upon the availability of funds and are revocable if the recipients' performance or use of funds is not consistent with the subaward terms. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | false | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | Yes (true) | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | false | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (14 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kevin Frost | ||||||||||||||
| Chief Executive Officer | $392,318 | $0 | $100,000 | $0 | $58,365 | $0 | $36,550 | $0 | $56,711 | $0 | $643,944 | $0 | $58,365 | $0 |
| Bradley Jensen | ||||||||||||||
| Assistant Treasurer, CFO | $245,632 | $0 | $0 | $0 | $0 | $0 | $17,401 | $0 | $38,604 | $0 | $301,637 | $0 | $0 | $0 |
| John F Logan JD PhD | ||||||||||||||
| AssT Sec, Vp, GEN COUNSEL | $228,897 | $0 | $0 | $0 | $0 | $0 | $16,120 | $0 | $12,575 | $0 | $257,592 | $0 | $0 | $0 |
| Rowena Johnston | ||||||||||||||
| Asst Secretary, Vice President | $187,484 | $0 | $0 | $0 | $0 | $0 | $13,201 | $0 | $12,575 | $0 | $213,260 | $0 | $0 | $0 |
| Edward Donnelly | ||||||||||||||
| Asst Treasurer, Controller | $151,164 | $0 | $0 | $0 | $0 | $0 | $11,019 | $0 | $11,536 | $0 | $173,719 | $0 | $0 | $0 |
| Eric Muscatell | ||||||||||||||
| Vice President of Development | $210,876 | $0 | $0 | $0 | $0 | $0 | $14,924 | $0 | $12,575 | $0 | $238,375 | $0 | $0 | $0 |
| Annette Sohn | ||||||||||||||
| Vice President, TREAT Asia PGM | $226,342 | $0 | $0 | $0 | $0 | $0 | $15,841 | $0 | $6,491 | $0 | $248,674 | $0 | $0 | $0 |
| AnnMarie Shannahan | ||||||||||||||
| Vice President, Public Info. | $216,462 | $0 | $0 | $0 | $0 | $0 | $15,231 | $0 | $12,575 | $0 | $244,268 | $0 | $0 | $0 |
| Andrew McInness | ||||||||||||||
| Director, Publications | $154,961 | $0 | $0 | $0 | $0 | $0 | $11,109 | $0 | $38,604 | $0 | $204,674 | $0 | $0 | $0 |
| Anthony Ancona | ||||||||||||||
| Vice President, Human Resource | $173,915 | $0 | $0 | $0 | $0 | $0 | $12,301 | $0 | $12,582 | $0 | $198,798 | $0 | $0 | $0 |
| Susan Doster | ||||||||||||||
| Chief Technology Officer | $141,709 | $0 | $0 | $0 | $0 | $0 | $10,338 | $0 | $29,754 | $0 | $181,801 | $0 | $0 | $0 |
| Bennah Serfaty | ||||||||||||||
| Sr Director of CommunicatiON | $123,037 | $0 | $0 | $0 | $0 | $0 | $8,830 | $0 | $38,604 | $0 | $170,471 | $0 | $0 | $0 |
| Gregorio Millet | ||||||||||||||
| Vice President, Public Policy | $180,559 | $0 | $0 | $0 | $0 | $0 | $12,852 | $0 | $12,080 | $0 | $205,491 | $0 | $0 | $0 |
| JONATHAN KEY | ||||||||||||||
| DIRECTOR, PHILANTHROPY | $178,219 | $0 | $0 | $0 | $0 | $0 | $9,545 | $0 | $29,754 | $0 | $217,518 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Compensation | FormAndLineReferenceDesc |
| Explanation | Part I, Line 4 Chief Executive Officer, Kevin Frost, participated in a supplemental nonqualified retirement plan. In calendar year 2015, Amfar contributed $60,000 into Mr. Frost's non-qualified retirement plan. This amount is not reported in Schedule J, Part II, Column (c) because the contributed amount was distributed to Mr. Frost within the same calendar year. Included in Schedule J column (b)(iii) is Mr. Frost's 2015 employer-funded 457(f) contribution of $60,000 plus payouts of previously contributed employer-funded 457(f) contributions (and earnings thereon). In Schedule J, part II, column (f), amfar is reporting $60,000 of 457(f) contributions that were recorded as deferred compensation on a previously filed Form 990. | ExplanationTxt |
Schedule M IRS990ScheduleM
| Field | Value | IRS element (for citing) |
|---|---|---|
| Works Of Art | WorksOfArtGrp | |
| Art Historical Treasures | ArtHistoricalTreasuresGrp | |
| Art Fractional Interest | ArtFractionalInterestGrp | |
| Books And Publications | BooksAndPublicationsGrp | |
| Clothing And Household Goods | ClothingAndHouseholdGoodsGrp | |
| Cars And Other Vehicles | CarsAndOtherVehiclesGrp | |
| Boats And Planes | BoatsAndPlanesGrp | |
| Intellectual Property | IntellectualPropertyGrp |
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 14 | ContributionCnt |
| Noncash Contributions Rpt F990 | $135,714 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | sales price | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities Closely Held Stock | SecuritiesCloselyHeldStockGrp | |
| Secur Prtnrshp Trust Intrsts | SecurPrtnrshpTrustIntrstsGrp | |
| Securities Miscellaneous | SecuritiesMiscellaneousGrp | |
| Qualified Contrib Hist Struct | QualifiedContribHistStructGrp | |
| Qualified Contrib Other | QualifiedContribOtherGrp | |
| Real Estate Residential | RealEstateResidentialGrp | |
| Real Estate Commercial | RealEstateCommercialGrp | |
| Real Estate Other | RealEstateOtherGrp | |
| Collectibles | CollectiblesGrp | |
| Food Inventory | FoodInventoryGrp | |
| Drugs And Medical Supplies | DrugsAndMedicalSuppliesGrp | |
| Taxidermy | TaxidermyGrp | |
| Historical Artifacts | HistoricalArtifactsGrp | |
| Scientific Specimens | ScientificSpecimensGrp | |
| Archaeological Artifacts | ArchaeologicalArtifactsGrp | |
| Any Property That Must Be Held | false | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | Yes (true) | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | false | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | Form 990, Schedule M, line 31 | FormAndLineReferenceDesc |
| Explanation | To the extent that amFAR receives non-standard contributions, the organization's policy is to liquidate those items into cash for eventual use in support of the organization's mission. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (9 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| Program Service Accomplishments(1) | Line 4a: Research: amfAR supports research projects that explore novel approaches to scientifically sound but untested hypotheses in all areas of research on HIV/AIDS, funding goal-oriented studies that often lack the preliminary data required for support from traditional grant makers. The Foundation plays a vital role in HIV/AIDS research, identifying critical gaps in knowledge and providing essential seed money that enables grantees and fellows to test the merits of new concepts or technologies that subsequently can be validated through large-scale studies, such as those funded by the U.S. National Institutes of Health. amfAR fellowships allow talented young investigators to conduct original investigations under the guidance of experienced scientists, helping to ensure the long-term vitality of AIDS research. New Grants and Fellowships Grants Grants and fellowships are awarded through a rigorous process of peer review by a team of independent HIV/AIDS experts drawn largely from the volunteer scientists on amfAR's Scientific Advisory Committee. Guided by its scientific advisors and with the approval of its board of trustees, amfAR pursues a strategic research plan that focuses on the pursuit of a cure for HIV/AIDS. Countdown to a Cure for AIDS In 2015, amfAR announced a $100 million investment strategy to support its Countdown to a Cure for AIDS initiative, which is aimed at developing the scientific basis for a cure by 2020. The strategy represents an unprecedented expansion of amfAR's grant making and is designed to provide support to any scientist or team of investigators for any research idea with the potential to advance the search for a cure, at any stage of its development. It is structured to provide sustained support for a wide range of studies that advance both emerging and established ideas. The strategy comprises the following components: - amfAR Institute for HIV Cure Research established in 2016 with a 20 million grant over five years to the University of California, San Francisco, the Institute is the cornerstone of amfAR's cure research efforts. - Innovation Grants These two-year awards of up to $200,000 each enable researchers to test innovative ideas supported by limited preliminary data. - Impact Grants These grants of up to $2 million each over four years support the in-depth development of concepts already underpinned by preliminary data showing genuine potential for achieving a cure. - Investment Grants Aimed at recruiting the experience and expertise of scientists from outside the field of HIV, these $1 million grants are awarded over a four-year period. Grantees may have expertise in fields such as cancer, neuroscience or inflammatory disease that can directly inform efforts to cure HIV. - ARCHE Launched in 2010, the amfAR Research Consortium on HIV Eradication, or ARCHE, supports collaborative teams of scientists in the U.S. and around the world working on a range of HIV cure strategies. - Opportunity Fund This funding mechanism will enable amfAR to respond quickly to emerging and unforeseen research opportunities. In just the first 24 months of the Countdown to a Cure for AIDS initiative, amfAR has supported 139 principal investigators and key personnel in 16 U.S. states and nine other countries around the world. Innovation Grants In June, amfAR announced a new round of Innovation Grants, totaling close to $1.4 million, to allow scientists to better understand why HIV persists in the body despite effective antiretroviral therapy and pursue novel pathways to a cure. The round of grants was supported in part by the Foundation for AIDS and Immune Research (FAIR). Among the grantees is Dr. Jonathan Karn of Case Western Reserve University in Cleveland, Ohio, who is aiming to develop a more accurate, cost - and time-efficient way to measure the size of the viral reservoir, which is essential for gauging the effectiveness of potentially curative interventions. Karns method could reduce the need for burdensome blood draws and greatly increase the number of patients who can be tested at one time. Another grantee, Dr. Maud Mavigner of Emory University in Atlanta, is conducting a comprehensive study to identify the most accurate methods to measure the viral reservoir in rhesus macaques infected with SIV, the non-human primate equivalent of HIV. SIV-infected rhesus macaques have helped answer some of the most crucial questions in HIV research. And a third grantee, Dr. Celsa Spina of the University of California, San Diego, is studying how and where HIV inserts itself into our DNA, enabling it to establish the hidden viral reservoir. The particular region can help determine whether the virus actively replicates or remains latent. The results of Spinas research will be important as we develop new drugs to target this reservoir. Investment grants In January 2016, amfAR awarded $1 million each over four years to Harvard physicist Dr. David Weitz and bioengineer and polymer scientist Dr. Alexander Zelikin of Aarhus University in Denmark. The two will collaborate with leading HIV researchers Drs. Bruce Walker and Martin Tolstrup at Harvard and Aarhus, respectively, in the effort to eradicate the viral reservoir, which is considered the principal barrier to curing HIV. Weitz proposes to isolate the most effective T cells from those that are less potent, clone them in a petri dish, and use a mouse model to test whether the reinjection of these killer cells can lead to a functional cure for HIV. An expert in prodrugs, Zelikin will design a two-component cocktail - one will gently reawaken the latent HIV and the second will specifically initiate the killing of virally infected cells. ARCHE (amfAR Research Consortium on HIV Eradication) In October 2015, amfAR provided $850,000 of renewal ARCHE funding to a consortium of European researchers who aim to replicate the case of the "Berlin patient," the first and only person known to have been cured of HIV. Diagnosed with leukemia, the patient was given a stem cell transplant with a twist: the cells he received were taken from a donor with a rare genetic mutation conferring resistance to HIV infection. Led by Dr. Javier Martinez-Picado of IrsiCaixa in Spain and Dr. Annemarie Wensing of University Medical Center Utrecht in the Netherlands, the team has already identified a group of patients who have undergone transplants and continues to monitor their progress in the hopes of generating new knowledge that can inform more widely applicable interventions. amfAR also awarded a $672,000 ARCHE grant in June to support a research team led by Dr. Timothy Schacker of the University of Minnesota, Minneapolis. Schacker is collaborating with a pair of leading investigators from the amfAR Institute for HIV Cure Research, Drs. Steven Deeks and Peter Hunt of the University of California, San Francisco (UCSF), to address one of the greatest challenges in HIV cure research: how to establish whether a person has been cured. Mathilde Krim Fellowships In October 2015, amfAR awarded a total of $600,000 in Mathilde Krim Fellowships in Basic Biomedical Research, an annual initiative that provides funding for exceptional young researchers who are new to the field of HIV/AIDS research. The program, which was created in 2008 in honor of amfARs founding chairman, has achieved spectacular results, including numerous published studies in major scientific journals. Each Krim Fellow receives $150,000 in funding over two years. Dr. Luis Agosto of Boston Medical Center is exploring one of the mechanisms that perpetuates the viral reservoir, with the goal of understanding how the virus evades the immune system. Dr. Liang Shan of Yale University in New Haven, CT, is using a humanized mouse model to test the efficacy of latency reversing drugs, studying their ability to reactivate HIV so that the immune system can kill those cells that harbor the virus. Dr. Louise Scharf of the California Institute of Technology in Pasadena is studying the molecular structure of broadly neutralizing antibodies isolated from two HIV-infected patients to better understand how these powerful antibodies can help in the development of a vaccine against the virus. And Dr. Amit Sharma of the Fred Hutchinson Cancer Research Center in Seattle, WA, is investigating how rhesus macaques can be better utilized as an animal model in HIV vaccine studies. Published Research Research studies make the greatest impact on the AIDS field and on the broader scientific community when they are published in scientific journals. In FY2016, 64 scientific publications resulted from amfAR-funded research. Examples include: Harnessing the Power of Antibodies Writing in the May issue of the journal Science, amfAR Krim Fellow Dr. Stylianos Bournazos and associates reported using a single broadly neutralizing anti-HIV antibody to target infected CD4 T cells in mice with a humanized immune system (i.e., mice that have been injected with human stem cells). Working i |
| Program Service Accomplishments (2) | Line 4b: TREAT ASIA: amfAR's TREAT Asia (Therapeutics Research, Education, and AIDS Training in Asia) program is a network of hospitals, clinics, and research institutions working with civil society to ensure the safe and effective delivery of HIV treatments to adults and children across the Asia-Pacific through research, education, and advocacy of evidence-based HIV-related policies. The TREAT Asia Network encompasses 21 adult and 19 pediatric sites throughout the region, which collaborate on a variety of projects. TREAT Asia scientists produced a record 34 publications in peer-reviewed medical journals in 2016. In 2016, amfAR successfully re-competed for funding for a new five-year cycle (2016-2021) that will be supported by the National Institute of Allergy and Infectious Diseases (NIAID), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Cancer Institute (NCI), and for the first time the National Institute of Mental Health (NIMH) and the National Institute on Drug Abuse (NIDA). The renewal application includes multiple studies that will be conducted across 58 institutions in 13 countries. The studies will help the program address emerging and critical issues facing people living with HIV who are transitioning from pediatric to adolescent care, and aging into older adults. TREAT Asia HIV Observational Database (TAHOD) TREAT Asia pioneered the region's first adult observational database for HIV/AIDS, which now includes anonymous data collected from approximately 9,000 patients at 20 clinical sites in 12 countries. The information gathered and analyzed through the database informs the development of more effective research and treatment programs, and helps define treatment standards specific to HIV/AIDS in Asia. International AIDS Database TREAT Asia manages the Asia-Pacific section of the International Epidemiologic Databases to Evaluate AIDS (IeDEA), a global collaboration established by the U.S. National Institute of Allergy and Infectious Diseases. In FY2016, the IeDEA consortium funded the second year of a study aiming to measure and better understand treatment adherence among young people with HIV. The study, which was conducted at the three participating IeDEA sites in Kenya, South Africa, and Thailand, evaluated factors that increase the risk of non-adherence and assessed the impact on treatment failure and clinic dropout. TREAT Asia Pediatric Network TREAT Asia's Pediatric Network includes 19 sites in six countries; these sites share information and best practices in an effort to improve the quality of pediatric care in the region. The TREAT Asia Pediatric HIV Observational Database (TApHOD) was modeled on the adult database and includes data from approximately 6,000 pediatric patients in Cambodia, India, Indonesia, Malaysia, Thailand, and Vietnam. TREAT Asia has been following a prospective cohort of 248 HIV-infected adolescents to evaluate multiple social, cultural, and behavioral factors that affect treatment adherence using an audio computer-assisted self-interview (ACASI) instrument at nine TApHOD sites in Malaysia, Thailand, and Vietnam. Among the study findings so far are that adolescents with effective virologic suppression are less likely to report high-risk sexual behaviors, such as inconsistent condom use. This emphasizes the need to promote and support strategies to achieve viral suppression as a key priority for adolescents who are struggling to adhere to antiretroviral therapy. This study was supported by the AIDS Life Foundation. Additional Adolescent Research In 2016, amfAR was awarded a Developmental Research Grant by the National Institutes of Health to improve how data on adolescents living with HIV are collected in resource-limited settings. The co-Principal Investigators- Treat Asia Director Dr. Annette Sohn and Dr. Mary-Ann Davies of the University of Cape Town, South Africa - are leading a team to establish a data collection and management platform that can guide clinical programs as to the socio-economic, clinical, and laboratory data needed to characterize how adolescents with HIV are transitioning to adult HIV care. The initiative, called GRADUATE: a Global fRAmework of Data collection Used for Adolescent HIV Transition Evaluation, will be implemented in Malawi, South Africa, and Thailand over the next two years. Expanding Pre-Exposure Prophylaxis (PrEP) for Female Sex Workers in Thailand In 2016, amfAR funded a study to assess combination HIV prevention needs, including pre-exposure prophylaxis (PrEP), among female sex workers in Bangkok and Pattaya, Thailand. The research team brings together experts from the Service Workers in Group (SWING) Foundation, a Thai advocacy organization for sex workers; Institute for Population and Social Research at Mahidol University in Bangkok; Johns Hopkins Bloomberg School of Public Health in Baltimore, MD; and amfAR. The researchers have collected data using focus groups, key informant interviews, and a questionnaire among 180 female sex workers to examine PrEP knowledge and acceptability and to document behavioral, social, and structural factors known to place women at risk for HIV. Addressing Unmet Needs in HIV Care In January 2016, TREAT Asia embarked on a think tank project to identify and address gaps in the management of HIV in Asia. The project is bringing together over 20 experts in HIV and other sub-specialties from Australia, China and Hong Kong SAR, India, Indonesia, the Philippines, South Korea, Taiwan, Thailand, Cambodia, Japan, Malaysia, and Vietnam. The think tanks are focusing on three priority areas: HIV and cardiovascular disease, HIV and liver disease, and HIV and drug resistance. Building Community Treatment Literacy and Promoting Advocacy for Treatment Access TREAT Asia works closely with regional organizations to support treatment literacy activities, including the production of "community-friendly" educational brochures on HIV treatment standards in local languages. In February and May 2016, TREAT Asia held two Youth ACATA (Asia Community for AIDS Treatment and Advocacy) workshops in Bangkok for young people living with HIV from Cambodia, Indonesia, and Thailand. In 2013, approximately 190,000 children and adolescents were living with HIV in the region. Launched in 2015 with support from ViiV Healthcares Positive Action for Adolescents program, Youth ACATA aims to educate participants about HIV and antiretroviral therapy and connects them to other HIV-positive youth in the region. In December 2015, Adams Love, the online HIV outreach initiative targeting gay men, other men who have sex with men (MSM), and transgender individuals (collectively, GMT) cut the ribbon on its new clinic in the heart of Bangkok. The clinic, established with support from amfAR, aims to appeal to discreet, harder-to-reach GMT individuals who might be hesitant to visit public government clinics for HIV testing and care. Part of an amfAR Implementation Science study, it will test three innovative HIV outreach and care models- each targeting a different subset of the GMT population. In addition, TREAT Asia continued to publish lay-language articles on AIDS research, policy, and community issues facing the TREAT Asia network and the Asia-Pacific as a whole. The articles and educational pieces appear in the TREAT Asia Report, a bimonthly e-newsletter, and on TREAT Asias website, www.treatasia.org. Treating HIV and Hepatitis C Co-Infection In May, TREAT Asia co-sponsored a one-and-a-half-day training in Bangkok for clinicians on treating hepatitis C and HIV co-infection with direct-acting antivirals (DAAs). More than 30 primary care and infectious disease physicians, patients, and treatment access advocates from six countries in South and Southeast Asia attended. The agenda included understanding steps for diagnosing hepatitis C infection, managing treatment side effects, and reviewing clinical care and treatment responses among people who inject drugs. TREAT Asia conducted the training in collaboration with the International Network for Hepatitis in Substance Users (INHSU) and the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). Expanded Access to Hepitatis C Treatments In August, TREAT Asia hosted its fourth regional strategic meeting on hepatitis C virus treatment access in Bangkok, with 22 participants from Cambodia, China, Indonesia, India, Malaysia, Nepal, Thailand, and Vietnam. The meeting included representatives from key population regional networks, including Mdecins Sans Frontires (MSF) Access Campaign, the Drugs for Neglected Diseases Initiative (DNDi), and the Lawyers Collective (a public interest service provider in India). Participants agreed to work with national partners to increase access to direct-acting antivirals by reducing regulatory barriers and ensuring affordable pricing. 15th Annual Network Meeting The 2015 TREAT Asia Annual Network Meeting was held Oct |
| Program Service Accomplishments (3) | Line 4c: PUBLIC INFORMATION: amfAR seeks to translate and disseminate information on important AIDS-related research, treatment, prevention, and policy issues for diverse audiences and to increase broad awareness and knowledge of the pandemic. amfAR also publishes a wide range of educational materials, maintains an informative website, and engages respected public figures, HIV/AIDS scientists, and policymakers in communicating the need for continued research to develop new methods of prevention, treatment, and, ultimately, a cure for AIDS. Educational Materials amfAR produces a range of periodicals in both print and electronic formats, including its newsletter Innovations, published twice a year and distributed to more than 45,000 people; the TREAT Asia Report, an e-mail newsletter distributed six times a year to more than 4,000 readers in the international health community; and a monthly e-mail newsletter distributed to nearly 100,000 people. The Foundation's website features news, interviews, blog posts, and original articles covering AIDS research, policy, the global epidemic, and amfAR programs and activiites. The website attracts an average of 40,000 visitors per month. amfAR also creates and distributes program reports, press releases, and updates on major HIV/AIDS issues and conducts public service advertising campaigns that have been instrumental in educating policymakers, healthcare professionals, people living with HIV/AIDS, and the general public. Social Media amfAR vigorously expanded its presence in the social media arena, reaching large numbers of people, including a younger demographic that is often less educated about HIV and the AIDS epidemic. The Foundation regularly adds content to its Facebook page, live tweets from events, and posts images on Instagram from fundraising and program events. amfAR has 72,000 likes on Facebook, 40,000 Twitter followers, and more than 108,000 Instagram followers. Media Outreach amfAR continued to work closely with the media to raise the profile of HIV/AIDS, both domestically and internationally, and to help ensure the accuracy of AIDS-related press coverage. Articles and reports involving amfAR-many of which included interviews with amfAR staff and spokespeople-were carried in numerous media outlets, including the New York Times, Forbes, The Advocate, CBS Radio, Reuters, Bloomberg News, and the South China Morning Post. Celebrity Support amfAR's public awareness efforts are greatly enhanced by the committed support of public figures who lend their voices and donate their time, talents, and resources to help sustain the Foundation's mission. Support of amfAR by prominent public figures began with the late Dame Elizabeth Taylor, amfAR's Founding International Chairman, and others have followed in her footsteps. amfAR is profoundly grateful for the continuing steadfast support of Global Campaign Chair Sharon Stone. In 2016, a collection of 1980s classic hits was updated by contemporary artists for The Time is Now!, a 14-track compilation album to benefit amfAR. The album features a soulful rendition of Michael Jacksons "Billie Jean" by singer-songwriter Aloe Blacc and a rendition of New Order's "Bizarre Love Triangle" performed by Sugar for Sugar, consisting of Scarlett Johansson, Julia Haltigan Holly Miranda, and Kendra Morris. The band Lower Dens, pop rock group DNCE, Dita Von Teese and Sebastien Tellier, and songwriting duo Marian Hill are also featured on the album. Other celebrity supporters included amfAR Ambassadors Milla Jovovich, Michelle Yeoh, and Cheyenne Jackson, Kathy Bates, Angela Bassett, Julia Roberts, Matt Bomer, Jamie Lee Curtis, Diane von Furstenberg, Gwyneth Paltrow, Chiara Ferragni, Ryan Murphy, Kevin Spacey, Lady Gaga, Diane Kruger, Uma Thurman, Dame Helen Mirren, Faye Dunaway, Katy Perry, Kate Moss, Marc Jacobs, Ricky Martin, amfAR Trustee Jay Ellis, Lea Michele, Michelle Rodriguez, Whoopi Goldberg, amfAR Trustee Harry Belafonte, Naomi Campbell, Heidi Klum, Riccardo Tisci, Adrien Brody, Eva Longoria, Harvey Keitel, Harvey Weinstein, Leonardo DiCaprio, Robert De Niro, Robin Thicke, Andrea Bocelli, Dean and Dan Caten, Chris Tucker, Jennifer Garner, Donatella Versace, and Carine Roitfeld. |
| Program Service Accomplishments (4) | Line 4d: THE GMT INITIATIVE: Since 2007, amfAR has been serving the HIV-related needs of gay men, other men who have sex with men (MSM), and transgender individuals (collectively, GMT) throughout the developing world through its GMT Initiative. Through small, targeted grants to grassroots groups, amfAR has expanded access to HIV education and prevention services; supported advocacy aimed at increasing funding for prevention and treatment services; and worked to end the stigma, discrimination, and violence that threaten the lives of GMT and fuel the spread of HIV/AIDS. In September 2015, amfAR awarded an 18-month grant to the Kirby Institute at the University of New South Wales in Sydney, Australia, to extend the Opposites Attract Study underway in Brazil and Thailand. The study is being led by Dr. Andrew E. Grulich of The Kirby Institute and is evaluating the role of combination antiretroviral therapy as a "treatment of prevention" strategy among serodiscordant male homosexual couples in Australia, Brazil, and Thailand. The same funding was used to support clinics at the Instituto de Pesquisa Clnica Evandro Chagas (IPEC) in Rio de Janeiro and the Thai Red Cross AIDS Research Centre in Bangkok, which have been participating in the study since May 2014. Implementation Science Awards In FY2016, amfARs grant making through the GMT Initiative evolved to support larger implementation science projects aimed at identifying barriers to HIV testing, treatment, and care and studying the impact of innovative HIV service delivery models for GMT in low- and middle-income countries. amfAR has awarded $2.6 million over three years to support three such studies. Dr. Chris Beyrer of Johns Hopkins University is leading a team of researchers and community-based services (in collaboration with the International HIV/AIDS Alliance Myanmar) in evaluating the effectiveness of promising interventions for GMT in Myanmar, where increased HIV testing and treatment opportunities are becoming available. The researchers are assessing the effectiveness of HIV self-testing done in the privacy of ones home, point-of-care CD4 testing, and the use of "peer navigators" familiar with the local health system to help those newly diagnosed gain access to HIV treatment and care. In Lima, Peru, Dr. Javier Lama of Asociacin Civil Impacta Salud y Educacin and his team are aiming to improve the continuum of care among transgender women by using an innovative model that integrates HIV prevention and treatment services with transgender-affirming medical care. Working in collaboration with the Boston-based Fenway Institute and two community GMT organizations, IMPACTA and EPICENTRO, Dr. Lama and his team are integrating routine cross-sex hormone therapy into HIV and sexually transmitted infection prevention, testing, and treatment services and implementing health services and peer case management for 200 transgender women. And in Bangkok, Thailand, Dr. Nittaya Phanuphak and her team at the Thai Red Cross AIDS Research Centre are working to show how innovative technologies such as GMT-targeted websites using online counseling and support can be utilized to increase rates of HIV testing and referrals to prevention and treatment programs. Working in collaboration with Adams Love, a web-based health platform for GMT individuals, and two community-based organizations (Service Workers in Group/SWING and The Rainbow Sky Association of Thailand), the team are comparing the effectiveness of online services and support interventions with traditional clinic-based HIV services, and a hybrid model that combines elements of both strategies. amfAR HIV Scholars Program In FY2016, amfAR supported four young researchers from Paraguay, Brazil, South Africa, and Indonesia undergoing five months of graduate-level public health study at the Center for LGBT Health Research of the Graduate School of Public Health at the University of Pittsburgh as part of the amfAR HIV Scholars Program. The program aims to strengthen GMT community-based research and responses to HIV, often in areas where little data about HIV among GMT currently exist and where stigma and discrimination deter many from seeking HIV testing and services. The 2016 amfAR HIV Scholars are Dr. Antonio Spagnolo of the National University of Asuncin in Paraguay; Daniel Dutra de Barros of Santa Casa de So Paulo School of Medical Sciences in Brazil; Kabelo Maleke of Project Boithato at the Anova Health Institute in rural South Africa; and Adi Nugroho of the GWL-INA Network in Jakarta, Indonesia. Publications As part of its efforts to raise awareness among governments, donors, and international nongovernmental organizations about the spread of HIV among GMT individuals and to advocate for effective strategies to address it, amfAR publishes a range of reports on HIV and GMT. In November 2015, amfAR - along with the International AIDS Vaccine Initiative (IVAI), the Johns Hopkins University- Center for Public Health and Human Rights (JHU-CPHHR), and the United Nations Development Program (UNDP)- released updated guidelines to Respect, Protect, Fulfill, a document that offers practical advice on how to engage gay men and other MSM in epidemiologic and intervention research, including HIV prevention and treatment trials. First released in 2011, the guidance helps researchers and community-based organizations maximize the benefits and minimize any potential risks of working together on critically needed research involving this population. The revised Respect, Protect, Fulfill was compiled through a participatory process that enlisted input from researchers and community leaders and organizations throughout the world. |
| Program Service Accomplishments (5) | Line 4d: public policy: Informed by thorough research and analysis, amfAR is a highly respected advocate of rational and compassionate AIDS-related public policy. The Foundation is engaged in efforts to secure necessary increases in funding for HIV/AIDS research; implement the U.S. National HIV/AIDS Strategy; expand access to care and treatment; and protect the civil rights of all people affected by HIV/AIDS. Shaping the Domestic Response to HIV/AIDS amfAR has long advocated the implementation of a comprehensive national HIV/AIDS strategy to address the epidemic in the U.S., where more than 1.2 million people are living with the virus. In February 2016, amfAR published an infographic titled, Small Increase, Big Impact, illustrating the declining purchasing power of the National Institutes of Healths (NIH) HIV/AIDS research dollars. In 2016, the NIH budget was increased by $2 billion, and President Obama proposed a further increase of $825 million for 2017. However, HIV research funding remained at 2015 levels. An increase in HIV research funding in line with the increase in total NIH funding would have meant an additional $76.6 million for HIV research for 2017. Such an increase would have allowed the NIH to fund 180 HIV/AIDS studies that could significantly advance HIV prevention, treatment or cure research; fund 51 clinical trials focused on curing HIV; or fund a breakthrough prevention trial. Key Populations amfAR is dedicated to addressing the needs of the people most vulnerable to HIV infection: men who have sex with men, sex workers, people who inject drugs, and transgender people. In October 2015, amfAR published Towards Defining an HIV Implementation Science Agenda for Key Populations in Low- and Middle-Income Countries based on a meeting the Foundation hosted in May 2015 to brainstorm how implementation science research might improve HIV outcomes for key populations in resource-limited settings. While significant progress has been made in the fight against AIDS, there remains a considerable gap between the potential of existing prevention and treatment tools and their actual impact on people affected by the virus. amfAR published Following the Money to Key Populations, National Priorities, and Evidence-Based Budgeting in June, a qualitative assessment of how Kenya and South Africa use health data for budgetary resource allocation. The Foundation, along with the Centre for Economic Governance and AIDS in Africa (CEGAA) and AVAC, reviewed resource allocation for health and HIV interventions, identified epidemiological data currently in use, highlighted information and procedural gaps in resource allocation for key populations, and developed recommendations for future research. In July, amfAR published the report Is PEPFAR Funding for Key Populations Aligned with the Epidemiologic Burden? based on an evaluation of the U.S. Presidents Emergency Plan for AIDS Relief (PEPFAR). Worldwide, 40-50% of all HIV infections in adults aged 15-49 occur among key populations. The report concluded that the disproportionate HIV risk along with poor quality health services underscore the continuing importance of prioritizing resources and targeted interventions. Global Health In FY2016, amfAR published The World Without PEPFAR, an infographic highlighting significant advances in global HIV/AIDS treatment and prevention made possible by the U.S. Presidents Emergency Plan for AIDS Relief (PEPFAR). Launched in 2003, PEPFAR made billions of dollars available for HIV programs in developing countries and fundamentally changed the course of the global epidemic. amfAR also added new features and data to its PEPFAR Country/Regional Operational Plan database, a comprehensive, navigable database of PEPFARs planned funding of HIV/AIDS activities from 2007 to 2015. Launched in 2015, the database is designed to help civil society organizations, ministries of health and finance, researchers, and other stakeholders access and understand PEPFARs programs and priorities on a deeper level than was possible using other platforms. |
| Policies | form 990, part vi, section b Line 11 - The Form 990 was prepared by a nationally renowned accounting firm in conjunction with the organization's financial department. A copy of the draft Form 990 was circulated to the full Board of Trustees for discussion and comment. Each Board Member was provided ample opportunity to comment on the information contained in the 990 prior to its filing with the Internal Revenue Service. Line 12 - Each officer, director, trustee and key employee of amFar ("foundation") is required to annually disclose any conflicts of interest that arise by virtue of employment, board service, or position with the foundation. The foundation monitors compliance with its conflict of interest policy through an annual questionnaire/disclosure statement that is distributed to these individuals. Potential conflicts are investigated immediately. LINE 15 - AMFAR ("FOUNDATION FOR AIDS RESEARCH") UNDERTAKES A THOROUGH PROCESS TO ENSURE THAT THE COMPENSATION IT PAYS TO ITS TOP MANAGEMENT OFFICIAL AND ALL OF ITS OFFICERS AND KEY EMPLOYEES IS REASONABLE GIVEN THE MARKET IN WHICH THE FOUNDATION OPERATES. AN INDEPENDENT CONSULTING FIRM QUALIFIED IN THE AREA OF NONPROFIT COMPENSATION PREPARES AN ANALYSIS OF MARKET COMPENSATION RANGES BY JOB FUNCTION AND PRESENTS IT TO THE COMPENSATION COMMITTEE OF THE BOARD. ON THE BASIS OF THIS INFORMATION, STAFF COMPENSATION IS DETERMINED ACCORDING TO SALARY RANGES APPROVED BY THE COMPENSATION COMMITTEE OF THE BOARD, IN CONSULTATION WITH THE CEO AND CFO. CEO COMPENSATION IS REVIEWED AND DETERMINED BY THE COMPENSATION COMMITTEE OF THE BOARD UTILIZING THE INDEPENDENT CONSULTANT ANALYSIS. |
| Disclosure | Form 990, Part VI, Section C LIne 19 - amfar makes its Form 990 available to the public by retaining a copy at its place of business and on its website, www.amfar.org. The Form 990 is likewise published on the internet at www.guidestar.org. The Foundation's financial statements are made available in its annual report and on its website. The Foundation's governing documents and conflict of interest policy are not ordinarily made available to the public, but, if requested, will be provided at management's discretion. |
| Functional Expenses | Part IX, Lines 1 & 3 The Foundation for AIDS Research reports its grants net of grant returns or recoveries. Periodically, grants remitted to charitable organizations are returned to AMFAR for a variety of reason. On Schedules F & I, grants are reported irrespective of whether they were ultimately returned to AMFAR since categorizing the "returned" amounts would be time consuming. Therefore, amounts reported on Part IX, Line 1 will not tie to total grants on Schedule I; amounts reported on Part IX, Line 3 will not tie to total grants on Schedule F. |
| OTHER CHANGES IN NET ASSETS | FORM 990, SECTION XI, LINE 9 CHANGE IN VALUE OF THIRD PARTY TRUST......... $2,183 ------- TOTAL LINE 9 $2,183 |
Comments